
Latest Acquisition Lands AxoSim in the News
News and BlogOn Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary—news of […]
Read MoreSelection of drug candidates is a difficult and imperfect process requiring predictive modeling. Too often, animal and other preclinical models are not predictive in humans. Without this knowledge, selection of the wrong candidate can result in losses of money, time, and resources. We aim to help navigate this path by providing rodent and human predictive in vitro modeling.
Our industry leading biomimetic platforms enable us to work with our clients and partners to apply predictive data assisting in identification of better drug candidates, earlier, and more accurately and efficiently.
1) Drug Discovery: Shortening the time to lead candidate selection with human targets in phenotypic assays.
2) Preclinical: Broadening the preclinical funnel while shortening the time to clinical candidate selection.
3) Clinical: Accelerating IND filing with improved translation a success.
AxoSim's NerveSim® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim® is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
The microBrain™ technology provides a physiologically-relevant human iPSC-derived screening platform for CNS drug discovery and toxicity testing.
On Tuesday, October 24, 2023, AxoSim announced the completion of its acquisition of the microBrain™-associated assets of Vyant Bio’s StemoniX subsidiary—news of […]
Read MoreNew Orleans, La. ─ October 24, 2023 ─ AxoSim, Inc., a leader in the development and application of live biomimetic human drug discovery platforms for […]
Read MoreWIRED recently quoted our Co-Founder Michael J. Moore and mentioned AxoSim and our 3D peripheral nerve model. The article highlights 3d printing […]
Read MoreTell us the school you attend, grade level and major. I am currently a senior at Tulane University majoring in cell and […]
Read MoreAt AxoSim, we frequently like to remind ourselves of our mission- empowering advancements in human neuroscience. We take a minute- away from the lab bench, protocols, schedules, budgets, and pipettes- and remember, that at the end of all the research, is people. Human beings that we know and love that are fighting daily battles with neurological diseases.